Literature DB >> 2322049

Reoperation for thymoma: report of 23 cases.

P A Kirschner1.   

Abstract

Twenty-three patients underwent reoperation for thymoma at intervals of 2 months to 17 years 10 months after the initial operation. There were no operative or hospital deaths. Myasthenia gravis occurred in 12 patients, but in only 2 was it a determinant for reoperation. The longest survival after reoperation is 12 years 9 months, and that patient is free from tumor. Four distinct surgical groups emerged, and their recognition provides an improved method of reporting and suggests a strategy for better overall management. Group 1 (n = 5) had completion of thymectomy (reoperation) after thymomectomy alone or after incomplete thymectomy. The interval was 2 months to 17 years 10 months. All 5 had myasthenia gravis. At reoperation, thymomas were found in 3 and a hyperplastic thymus in 2. Four are alive and tumor free 2 years to 8 years 2 months after reoperation. One died tumor free after 5 years. Group 2 (n = 8) had reoperation for recurrent thymoma after standard (presumably complete) resection. The interval was 2 years to 13 1/2 years. Four had myasthenia gravis. Four are alive 8 months to 5 years 8 months after reoperation, 3 without detectable tumor. Four died 3 years 3 months to 8 years 4 months after reoperation, 3 free from tumor. Group 3 (n = 8) underwent reoperation for initially unresectable thymoma after adjuvant treatment with chemotherapy, radiotherapy, or both. The interval was 3 months to 4 years 8 months. Three had myasthenia gravis. Six are alive 4 months to 4 years after reoperation, only 1 with tumor.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2322049     DOI: 10.1016/0003-4975(90)90300-u

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

Review 1.  Thymectomy for myasthenia gravis.

Authors:  J D Urschel; R P Grewal
Journal:  Postgrad Med J       Date:  1998-03       Impact factor: 2.401

2.  Thymoma. Analysis of prognostic factors.

Authors:  M Sonobe; M Nakagawa; M Ichinose; N Ikegami; M Nagasawa; T Shindo
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-01

3.  Tiny thymic carcinoma completely surrounded by thymic tissue. The possibility of de novo carcinoma.

Authors:  A Kitami; T Suzuki; S Suzuki; G Hori
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-10

4.  Observation and extirpation of a giant-size type-B2 thymoma IIb with its histological, macroscopic, and computer tomogram correlate, and literature review.

Authors:  Maximilian de Bucourt; Marc Swierzy; Anja Dankof; Ulf Teichgräber; Jens-Carsten Rückert
Journal:  Rare Tumors       Date:  2010-06-30

5.  Video-assisted thoracoscopic management of mediastinal tumors.

Authors:  Y J Cheng; H H Wu; S H Chou; E L Kao
Journal:  JSLS       Date:  2001 Jul-Sep       Impact factor: 2.172

6.  Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience.

Authors:  A Berruti; P Borasio; A Gerbino; G Gorzegno; T Moschini; M Tampellini; F Ardissone; M P Brizzi; A Dolcetti; L Dogliotti
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.